Literature DB >> 29285641

Core Body Temperature but Not Intraabdominal Pressure Predicts Postoperative Complications Following Closed-System Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Administration.

M Goldenshluger1, D Zippel1, A Ben-Yaacov1, J Dux1, T Yalon1, A Zendel1, S Rayman1, E Mor1, H Berkenstadt2, H Fogel-Grinvald3, M Ventorrero1, A Nissan4.   

Abstract

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS), performed using closed-abdomen technique (CAT), may affect intraabdominal pressure (IAP). High IAP may increase postoperative complications due to decreased venous return and hypoperfusion to vital organs. Elevated core body temperature (CBT) may cause multiorgan dysfunction. Low IAP or CBT could result in suboptimal HIPEC and potentially translate into early disease recurrence. The aim of the present study is to identify possible correlations between IAP or CBT and postoperative complications. PATIENTS AND METHODS: Continuous intraabdominal pressure measurement was performed by intraabdominal catheter. Inflow temperature was set at 44 °C, and mean perfusate temperature was 42 °C. CBT was measured continuously in the distal esophagus. We compared the rate of postoperative complications between the low IAP group (2-10 mmHg, n = 28), target IAP group (10-20 mmHg, n = 71), and high IAP group (20-34 mmHg, n = 16) as well as with CBT as a continuous variable.
RESULTS: 115 patients were included in the study. There was no difference between IAP groups in terms of age, gender, primary diagnosis, operative peritoneal cancer index, CBT, or operative time. There was no correlation between IAP and postoperative complications or with prolonged hospital stay. On multivariate analysis, elevated mean CBT was a positive predictor of postoperative complications (p = 0.035).
CONCLUSIONS: IAP level during closed-abdomen technique HIPEC is not associated with postoperative complications. However, elevated CBT may increase postoperative complications.

Entities:  

Mesh:

Year:  2017        PMID: 29285641     DOI: 10.1245/s10434-017-6279-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

Review 1.  Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis.

Authors:  Mikkel Lundbech; Andreas Engel Krag; Lene Hjerrild Iversen; Anne-Mette Hvas
Journal:  Int J Colorectal Dis       Date:  2021-10-09       Impact factor: 2.571

2.  Risk of Intraoperative Hyperthermia and Outcomes in Adults Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Carlos E Guerra-Londono; Pascal Owusu-Agyemang; German Corrales; Marina M Rofaeil; Lei Feng; Keith Fournier; Juan P Cata
Journal:  Ann Surg Oncol       Date:  2021-10-26       Impact factor: 5.344

3.  Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial.

Authors:  Miao-Fang Wu; Li-Juan Wang; Yan-Fang Ye; Chang-Hao Liu; Huai-Wu Lu; Ting-Ting Yao; Bing-Zhong Zhang; Qing Chen; Ji-Bin Li; Yong-Pai Peng; Hui Zhou; Zhong-Qiu Lin; Jing Li
Journal:  BMJ Open       Date:  2021-12-16       Impact factor: 2.692

4.  Application Effect of Intra-Abdominal Pressure Monitoring System in Early Enteral Nutrition Nursing of ICU Patients.

Authors:  Meiling Song; Peiru Zhao; Wenjun Hu
Journal:  Contrast Media Mol Imaging       Date:  2022-01-29       Impact factor: 3.161

5.  In-vivo thermodynamic exploration of gas-based intraperitoneal hyperthermia.

Authors:  Agata Diakun; Tanja Khosrawipour; Agata Mikolajczyk-Martinez; Piotr Kuropka; Jakub Nicpoń; Zdzisław Kiełbowicz; Przemysław Prządka; Bartłomiej Liszka; Shiri Li; Hien Lau; Wojciech Kielan; Veria Khosrawipour
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

Review 6.  Peritoneal mesothelioma.

Authors:  Alissa Greenbaum; H Richard Alexander
Journal:  Transl Lung Cancer Res       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.